Aequs (AEQUS) Q2 FY27: Sales Up 45%, EBITDA Down 45%, Net Loss ₹52 Cr
Aequs (AEQUS) Q2 FY27 sales rose 45% to ₹409 crore, but EBITDA fell about 45% and the net loss was ₹52 crore; the stock is ₹224 against a ₹124 IPO price.
Aequs Limited (NSE: AEQUS, BSE: 544634) - Share price: ₹224 (20 November 2026 close, screener.in) - Market cap: about ₹15,023 crore - P/E: not meaningful, because the company makes a loss (last twelve months: -₹202 crore) - Price to book value: about 10.8 times (book value is what would be left per share after paying all debts: ₹20.8) - Closest listed peers: Azad Engineering ₹15,121 crore market cap and P/E 110; Unimech Aerospace ₹9,072 crore and P/E 103 (screener.in, same day) - Listing: mainboard, on NSE and BSE since 10 December 2025 (not an SME stock)
Aequs is a precision manufacturer, mostly of aircraft parts, that listed less than a year ago. This article uses the Q2 FY27 earnings call and the company's investor presentation to cover what the IPO looked like, who the big buyers were, and how the business has done since. It also covers whether the price today asks too much. The big picture in one line: the aerospace business is growing and profitable, but the new consumer business is losing money faster than management planned, and it just pushed its break-even date.
Aequs Q2 FY27 results: sales up 45%, EBITDA down about 45%
Aequs was incorporated on 27 March 2000 and runs a vertically integrated precision-manufacturing campus in Belagavi, Karnataka. It has two segments. Aerospace makes engine, landing-gear, structure and assembly parts for Airbus, Boeing, Safran, Collins and SAAB. Consumer makes toys (Mattel) and metal enclosures for a large consumer-electronics brand, and also has a joint venture with Tramontina for houseware.
The latest numbers are for the September 2026 quarter, reported on 26 October 2026. EBITDA is operating profit before interest, tax and depreciation:
Item Q2 FY27 Change --------- Sales ₹409 crore +45% year on year Aerospace sales ₹351 crore (86% of total) +44% Aerospace EBITDA ₹78 crore, about 22% margin +24% Consumer sales ₹58 crore +52% Consumer EBITDA -₹40 crore loss was ₹7.7 crore a year ago Total EBITDA ₹24.5 crore, 6% margin down about 45% from roughly ₹45 crore; margin was 16% a year ago Net loss ₹52 crore ₹53 crore in the June quarter and about ₹21 crore a year ago
The segment figures do not add up to the total (₹78 crore less ₹40 crore is ₹38 crore, not ₹24.5 crore), because the total also carries corporate and other costs. The call did not give that split.
For the first half (April to September 2026), sales were ₹805 crore, up 50%. The net loss was ₹105 crore against ₹17 crore a year earlier, about six times larger. The company says three things explain the gap (these are management's own explanations): depreciation of the new consumer plants is now charged to profit (last year it was a pre-opening cost), the cost of new product variants and extra staff, and higher tax on the profitable aerospace units.
Did Aequs deliver what it promised?
The one date that slipped. Management said earlier that the consumer business would turn EBITDA-positive by Q4 FY27 (January to March 2027). On the Q2 call it said the date is being "recalibrated" and gave no new one.
Promise (source) What happened Verdict --------- Consumer EBITDA positive by Q4 FY27 (earlier calls) Q2 consumer EBITDA loss ₹40 crore, wider than ₹36 crore in Q1. No new date given. Plan withdrawn, no new date given Consumer to reach profit after tax by FY30 (earlier guidance, repeated on the Q2 call) Not yet testable Open Consumer plant use of 40-50% (Q2 call target) Consumer electronics plant used 17% in Q2, down from 22% Behind Aerospace "on track" for FY27 H1 aerospace sales +42%, EBITDA +29% On track so far Capex of ₹660 crore in FY27 (earlier guidance) ₹160 crore spent in H1. Management says it "may end up doing much lesser". Cut back Inventory near 120 days (guided) 155 days in September 2026, from 168 in March 2026 Not yet
The company gave reasons for the consumer delay. A product update at the electronics plant took longer to approve, and some toy parts were short because of supply problems and bad weather. The old toy customer is also phasing out while Mattel ramps up. In April 2026 Hasbro told the toy subsidiary it intends to stop placing orders. Management expects Mattel to make up almost the whole toy business by Q4 FY27.
Aequs IPO recap: price, anchors and the pre-IPO round
- Issue size: ₹921.8 crore, made up of a fresh issue of ₹670 crore and a sale of ₹251.8 crore by existing holders (Amicus Capital funds, the Melligeri Private Family Foundation and others). - Price band: ₹118 to ₹124. Open 3 to 5 December 2025. It was subscribed 57.98 times. - Pre-IPO round: ₹144 crore at ₹123.97 a share from SBI Emergent India Fund, DSP India Fund, SBI Optimal Equity Fund and Think India Opportunities Master Fund. - Listing: 10 December 2025, at about ₹140 against the ₹124 issue price. - What the money was for: ₹433.2 crore to repay loans, ₹64 crore for machines and ₹125.2 crore for acquisitions and general use. By 28 October 2026, the monitoring agency showed ₹547 crore of the ₹622 crore net proceeds used, and ₹75 crore not yet used. All the loan repayment is done.
Anchor investors. On 2 December 2025, 33 anchors put in ₹413.92 crore at ₹124 a share:
Anchor type Amount Share of anchor book --------- Mutual funds ₹232.22 crore 56.1% Foreign portfolio investors ₹154.38 crore 37.3% Alternative investment funds ₹22.31 crore 5.4% Insurers ₹5.00 crore 1.2%
An anchor investor is a large fund that commits money just before an IPO opens. The two biggest named anchors were Smallcap World Fund (₹50 crore) and SBI MNC Fund (₹30 crore, SBI Mutual Fund). Press reports also name HDFC, ICICI Prudential, Axis and Motilal Oswal mutual funds, BlackRock Global Funds, Steadview Capital and Citigroup. The two anchor lock-ins ended on 6 January and 7 March 2026. An anchor is only a buyer at the IPO: the end of a lock-in does not mean it sold, so the next section shows who actually holds shares now.
Who owns Aequs now?
Holder Dec 2025 Sep 2026 --------- Promoters 59.08% 59.09% FIIs (foreign funds) 4.05% 5.93% DIIs (Indian mutual funds, insurers) 11.63% 9.28% Public 22.88% 23.46% Others 2.36% 2.26%
Holders above 1% in the September 2026 pattern, per the shareholding table: - Amansa Investments: 5.49% (it was 7.48% until June 2026, so it sold) - Steadview Capital Mauritius: 3.40% - Catamaran Ekam: 2.83% - Smallcap World Fund: 2.21% - SBI MNC Fund: 2.08%
SBI Children's Fund held 1.89% in June 2026 and is not in the September list. HDFC Mutual Fund, which was in the anchor book, does not show as a 1% holder now. Amicus Capital Partners India Fund II (1.45% in December 2025) is also no longer in the list. Institutions as a group have trimmed since listing, even though foreign funds have added.
Aequs valuation: how it compares with Azad and Unimech
The RHP names its listed peers. Here is its table (prices of 21 November 2025, financial year 2025 earnings), with today's figures for the two closest aerospace names:
Company P/E in the RHP (21 Nov 2025) Return on net worth P/E today (screener.in) Market cap today --------------- Aequs Not ascertainable (loss) -14.47% Loss-making ₹15,023 crore Azad Engineering 115.5 6.21% 110 ₹15,121 crore Unimech Aerospace 55.7 12.48% 103 ₹9,072 crore Amber Enterprises 100.4 10.99% not checked not checked Kaynes Technology 129.6 10.33% not checked not checked Dixon Technologies 73.9 47.50% not checked not checked PTC Industries 417.0 4.40% not checked not checked
With earnings negative, P/E cannot be used. Price to book value gives one comparison point, but read it with care: Aequs is loss-making, has negative operating cash flow and still invests heavily, and its business mix (a big consumer arm) differs from these peers. Aequs is at about 10.8 times book, Azad about 9.5 times and Unimech about 11.4 times. A buyer at this price is paying for future growth, even though Aequs's returns are far below theirs today. Its ROCE is 1.7% and return on equity is -10% (screener.in). At the ₹124 cap price the book-value multiple was about 5 times on the RHP's post-issue book value of ₹24.74 a share.
Is Aequs profit turning into cash?
No, not yet. In FY26 the company made operating profit (EBITDA) of ₹92 crore but its cash from operations was -₹99 crore. EBITDA ignores money tied up in stock and customer dues, so a company can show an operating profit and still burn cash. Here the "other assets", which include inventory and customer dues, rose from ₹906 crore to ₹1,478 crore in FY26 (screener.in).
Year (March) FY23 FY24 FY25 FY26 --------------- EBITDA (₹ crore) 40 129 79 92 Cash from operations (₹ crore) 10 -19 26 -99 Debtor days (screener.in) 48 52 62 78 Inventory days (screener.in) 313 336 420 450 Payable days (screener.in) 215 177 215 238
The company's own working-capital days for September 2026 use a different method from the screener.in rows above, so the two sets are not directly comparable (inventory is not suddenly down from 450 days to 155). On the company's own method, September is better than March: receivable days 68 (from 78), inventory days 155 (from 168) and payable days 87 (from 96). Net working capital is 136 days against 151. Management expects inventory to ease from about Q1 FY28. I did not read the RHP's rupee receivable table, so I cannot give the exact crore figure of customer dues; the days above show the trend. Fixed assets were ₹1,070 crore against total assets of ₹2,733 crore at March 2026, so this is a heavy-asset business, not an asset-light one.
Borrowings rose by ₹158 crore in the first half to fund machines and working capital. Net debt to equity went to 0.5 times from 0.2 times in March. Cash was ₹171 crore.
Fundraising: promoter warrants at ₹231.55
A warrant is a right to buy a share later at a fixed price. On 25 September 2026 the board approved 2.81 crore convertible warrants at ₹231.55 each, worth ₹650 crore, for the Melligeri Private Family Foundation (a promoter trust). The shareholders approved it at an extra-general meeting on 22 October, and the allotment was on 5 November 2026. Half (₹325 crore) was paid up front. The other half is due when the warrants turn into shares, on or before 31 December 2027.
- Dilution: the 2.81 crore warrants equal about 4.2% of the 67 crore shares now in issue, or about 4.0% of the total after they convert. - Price comparison: the warrant price is about 3% above today's ₹224, so the promoters are paying roughly the current price. - Planned use: about ₹289 crore for machines (including Hosur), ₹100 crore for working capital, ₹100 crore for joint ventures and new projects, and the rest for general use. - More money to come: management said it still sees a possible equity raise in FY28, plus about ₹800 crore of new term loans. - Group tidy-up: a plan to merge three wholly owned subsidiaries into Aequs was not approved under the fast-track route, and the company is deciding what to do next.
What management says is next (its own forward-looking statements)
These are the company's statements, not facts, and not promises.
- Revenue: it is "not deterring away" from growing sales 4 to 6 times by 2031 (it gave no base year on the call). - Aerospace: "on target" for FY27. Order book of USD 1.1 billion, up 9% in the quarter. It usually plays out over 5 to 7 years, with some contracts as long as 15. - Parts and machines: 238 new parts added in the quarter (5,978 in total), 229 CNC machines, 2.12 million machining hours a year. Aerospace plant use was 69% for the group and 76% in India. - Safran: a new long-term agreement signed with six Safran entities after the quarter, including landing-gear work for the new Hosur site. - Hosur (Tamil Nadu): a 250-acre site for engine and landing-gear parts (titanium, superalloys and steels), with forging, ring rolling and testing. First-phase investment starts in Q4 FY27 and commercial production in FY29. - Consumer: break-even at about 50% plant use. It is targeting 40-50% use. Profit after tax is expected only by FY30. Management says it has no plan to add 3D printing. - Capex: lower than ₹660 crore in FY27, with more going to aerospace than consumer. - Inventory: aiming for about 120 days.
Risks and red flags
- Customer concentration: the ten largest customer groups gave 88.57% of revenue in FY25, and aerospace was 89% of revenue (RHP). - Contracts need not buy a fixed amount; they are requirement-based (RHP). - Tax case: the tax department has raised a ₹77.96 crore demand against the company over money received from a promoter-linked person. The company has appealed, and the High Court matter is pending (RHP). - Consumer losses are widening because most costs are fixed while volumes fell from ₹73 crore to ₹58 crore of sales between Q1 and Q2. - Hasbro has said it intends to stop placing orders with the toy subsidiary. - Funding need: more equity and ₹800 crore of loans are planned, so dilution and interest costs may keep rising. - The company is still loss-making. Its 52-week high is ₹295 and low is ₹113; today's ₹224 is 24% below the high.
Management's profile: Aravind Melligeri is Executive Chairman and CEO, Rajeev Kaul is Co-Founder and Managing Director, and Reenah Joseph recently joined as CFO with nearly two decades in corporate finance, capital markets and M&A. The promoters hold 59.09%: Aequs Manufacturing Investments (43.35%), the Melligeri Private Family Foundation (14.99%) and family members and others (about 0.75% together). The RHP records no SEBI action against the promoters. I did not find ages or career details for these people in the documents I read, so I have not stated them.
Should you buy Aequs at ₹224?
Management's break-even point and the order book are estimates, not guarantees: reaching 50% plant use does not by itself make the consumer arm profitable, and the order book is not guaranteed sales because contracts are requirement-based.
The case for: aerospace sales are growing about 44% a year, margins on that side are near 22%, and the order book is USD 1.1 billion. The case against: the group loses ₹52 crore a quarter, the consumer break-even date has gone, cash from operations is negative, and the stock already trades near 11 times book value, the same as profitable peers. Anyone considering it should watch two things: consumer plant use climbing toward 50%, and operating cash turning positive. At ₹224, a buyer is paying for improvements that have not happened yet, and the timing of both is uncertain: the consumer break-even date has been withdrawn and cash flow has no stated target date.
Note: I am not a SEBI-registered investment advisor. This article is for educational purposes only and is not investment advice. Please consult a registered financial advisor before making investment decisions.
Sources
- https://www.chittorgarh.com/ipo/aequs-ipo/2465/ - https://www.chittorgarh.com/iposubscription/aequs-ipo/2465/ - https://www.jmfl.com/Common/getFile/5425 (abridged prospectus, RHP dated 26 November 2025) - https://www.jmfl.com/Common/getFile/5427 (Basis for Offer Price section of the RHP) - https://www.jmfl.com/Common/getFile/5504 (JM Financial track-record sheet, updated 15 November 2026) - https://www.aequs.com/wp-content/uploads/2026/10/Transcript-Q2-FY27.pdf (Q2 FY27 earnings call, 26 October 2026) - NSE filings by Aequs: investor presentation of 18 June 2026, board outcome of 25 September 2026, warrant allotment of 5 November 2026, Hasbro intimation of 20 April 2026 (https://www.nseindia.com/companies-listing/corporate-filings-announcements) - https://inc42.com/?p=540536 (anchor round report)